Edesa Biotech (EDSA) Short Interest Ratio & Short Volume → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free EDSA Stock Alerts $4.42 +0.11 (+2.55%) (As of 04/25/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Edesa Biotech Short Interest DataCurrent Short Volume15,200 sharesPrevious Short Volume19,500 sharesChange Vs. Previous Month-22.05%Dollar Volume Sold Short$62,624.00Short Interest Ratio / Days to Cover1.2Last Record DateApril 15, 2024Outstanding Shares3,216,000 sharesFloat Size2,340,000 sharesShort Percent of Float0.65%Today's Trading Volume2,358 sharesAverage Trading Volume12,194 sharesToday's Volume Vs. Average19% Short Selling Edesa Biotech ? Sign up to receive the latest short interest report for Edesa Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatEDSA Short Interest Over TimeEDSA Days to Cover Over TimeEDSA Percentage of Float Shorted Over Time Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> Edesa Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202415,200 shares $62,624.00 -22.1%0.7%1.2 $4.12 3/31/202419,500 shares $81,738.15 +10.2%0.8%1.4 $4.19 3/15/202417,700 shares $77,703.00 +4.1%0.8%1.2 $4.39 2/29/202417,000 shares $77,860.00 +11.8%0.7%0.6 $4.58 2/15/202415,200 shares $85,880.00 -27.6%0.7%0.5 $5.65 1/31/202421,000 shares $93,450.00 +2,525.0%0.9%0.7 $4.45 Get the Latest News and Ratings for EDSA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Edesa Biotech and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024800 shares $3,728.00 -93.4%0.0%0 $4.66 12/31/202312,100 shares $55,297.00 -61.7%0.5%0.1 $4.57 12/15/202331,600 shares $164,004.00 +1,404.8%1.4%0.3 $5.19 11/30/20232,100 shares $6,930.00 -91.0%0.1%0 $3.30 11/15/202323,200 shares $67,280.00 -21.6%1.1%0.3 $2.90 10/31/202329,600 shares $95,312.00 -50.3%1.4%0.4 $3.22 10/15/202359,500 shares $235,322.50 -80.2%2.8%0.8 $3.96 9/30/2023300,200 shares $1.33 million -4.9%N/A3.5 $4.42 9/15/2023315,500 shares $283,950.00 -0.9%N/A6.5 $0.90 8/31/2023318,200 shares $269,515.40 -49.7%N/A5.8 $0.85 8/15/2023632,100 shares $537,285.00 -1.4%N/A11.5 $0.85 7/31/2023641,300 shares $525,866.00 -0.1%N/A10.8 $0.82 7/15/2023641,700 shares $534,471.93 -3.2%N/A8.9 $0.83 6/30/2023662,800 shares $530,240.00 +5.0%N/A9.6 $0.80 6/15/2023631,000 shares $542,218.30 -0.1%N/A8.7 $0.86 5/31/2023631,800 shares $574,938.00 -1.2%N/A7.9 $0.91 5/15/2023639,600 shares $562,911.96 -12.4%N/A8 $0.88 4/30/2023730,500 shares $818,160.00 -20.0%N/A8.6 $1.12 4/15/2023913,300 shares $958,965.00 +0.8%N/A9.5 $1.05 3/31/2023906,500 shares $826,818.65 +10.9%N/A4.9 $0.91 3/15/2023817,300 shares $980,760.00 +19.3%N/A1.7 $1.20 2/28/2023685,300 shares $979,979.00 +6.3%N/A1.4 $1.43 2/15/2023644,500 shares $928,080.00 -17.6%N/A1.3 $1.44 1/31/2023781,700 shares $1.17 million +16.7%N/A1.6 $1.50 1/15/2023669,600 shares $1.69 million -17.8%N/A1.4 $2.52 12/30/2022815,000 shares $1.76 million +111.0%N/A2.1 $2.16 12/15/2022386,300 shares $370,732.11 +4.4%3.2%0.9 $0.96 11/30/2022369,900 shares $341,121.78 +4.3%3.9%1.9 $0.92 11/15/2022354,800 shares $325,316.12 +6.2%3.7%1.8 $0.92 10/31/2022334,000 shares $344,020.00 +10.5%3.5%1.7 $1.03 10/15/2022302,300 shares $292,535.71 +484.7%3.0%1.5 $0.97 9/30/202251,700 shares $47,631.21 -38.7%0.5%0.3 $0.92 9/15/202284,300 shares $148,368.00 -11.9%0.8%1.2 $1.76 8/31/202295,700 shares $179,916.00 +476.5%1.0%1.3 $1.88Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> EDSA Short Interest - Frequently Asked Questions What is Edesa Biotech's current short interest? Short interest is the volume of Edesa Biotech shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 15,200 shares of EDSA short. 0.65% of Edesa Biotech's shares are currently sold short. Learn More on Edesa Biotech's current short interest. What is a good short interest ratio for Edesa Biotech? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EDSA shares currently have a short interest ratio of 1.0. Learn More on Edesa Biotech's short interest ratio. What is a good short interest percentage for Edesa Biotech? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.65% of Edesa Biotech's floating shares are currently sold short. Is Edesa Biotech's short interest increasing or decreasing? Edesa Biotech saw a decline in short interest in the month of April. As of April 15th, there was short interest totaling 15,200 shares, a decline of 22.1% from the previous total of 19,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Edesa Biotech's float size? Edesa Biotech currently has issued a total of 3,216,000 shares. Some of Edesa Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Edesa Biotech currently has a public float of 2,340,000 shares. How does Edesa Biotech's short interest compare to its competitors? 0.65% of Edesa Biotech's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Edesa Biotech: ABVC BioPharma, Inc. (6.14%), NeuroBo Pharmaceuticals, Inc. (2.63%), Aytu BioPharma, Inc. (7.51%), Kiora Pharmaceuticals, Inc. (0.31%), Avalo Therapeutics, Inc. (14.89%), Tonix Pharmaceuticals Holding Corp. (1.76%), MIRA Pharmaceuticals, Inc. (0.43%), Cocrystal Pharma, Inc. (0.02%), RedHill Biopharma Ltd. (2.51%), Talphera, Inc. (0.65%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Edesa Biotech stock? Short selling EDSA is an investing strategy that aims to generate trading profit from Edesa Biotech as its price is falling. EDSA shares are trading up $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Edesa Biotech? A short squeeze for Edesa Biotech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EDSA, which in turn drives the price of the stock up even further. How often is Edesa Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EDSA, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ABVC BioPharma Short Interest Data NeuroBo Pharmaceuticals Short Interest Data Aytu BioPharma Short Interest Data Kiora Pharmaceuticals Short Interest Data Avalo Therapeutics Short Interest Data Tonix Pharmaceuticals Short Interest Data MIRA Pharmaceuticals Short Interest Data Cocrystal Pharma Short Interest Data RedHill Biopharma Short Interest Data Talphera Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EDSA) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings